Recently, the invention patent (patent number: ZL 202110961634.3) declared by Anhui Guopeptide Biotechnology Co., Ltd., a subsidiary of the People's Guopeptide Group, has been successfully approved by the State Intellectual Property Office, which not only marks that the People's Guopeptide Group has made a major breakthrough on the road of scientific research and innovation, but also means that Guopeptide has mastered the key core technology of the second-generation bioactive peptide "nanoparticle peptide". It will accelerate the upgrading and iteration of the mainland peptide industry into the "second generation", providing "new quality productivity" for the high-quality development of the peptide industry.
The invention patent of [a preparation method and application of ternary polypeptide nanoparticles based on yak bone peptide] successfully approved by the national peptide has many characteristics such as advanced technology, high scientific and technological content, and strong applicability. The present invention is based on yak bone peptide to develop a preparation method of ternary polypeptide nanoparticles based on yak bone peptide. Based on the characteristics of yak bone peptide, by changing its secondary structure and co-shelf with other nutritional polypeptides to form a new and stable secondary structure, it was prepared as polypeptide nanoparticles, through the formation of a co-shelf composite system, the solubility and dispersion of each polypeptide in the composite system were increased, and the nanoparticles had high particle size uniformity and stability, which had a very wide range of scientific research and application value.
For a long time, the processing and preparation of nanoparticle peptides has been a major difficulty in the industry. Through this invention patent, Guopeptide provides a new preparation method of ternary polypeptide nanoparticles based on yak bone peptide. At the same time, on the basis of retaining the integrity of the primary structure of the protein to the greatest extent, the secondary structure of the protein can be changed through interaction, and the nutritional complementarity can be achieved through the combination of different proteins, so as to improve the potential application value of yak bone peptide.
In recent years, under the guidance of the strategy of "strengthening the enterprise with science and technology", the People's Republic of China Peptide Group has continuously strengthened its investment in scientific research and innovation, and promoted the high-quality and vigorous development of the enterprise with high-level scientific research and innovation achievements. Up to now, the national peptide patent matrix library has exceeded more than 120 items, not only involving antioxidant, hypoglycemic, blood pressure, anti-fatigue, improving immunity, enhancing bone density and other functional fields, but also covering yak bone peptide, cod peptide, oyster peptide, sea cucumber peptide, walnut peptide, polygonatum peptide and other animal and plant and Chinese herbal medicine product categories, which have been highly recognized by the national market and customers.
It is worth mentioning that in the field of yak bone peptide, national peptide can be said to have been at the forefront of the industry. In addition to the newly approved nanoparticle yak bone peptide patent technology, Guopeptide has also successfully applied for "a yak bone collagen peptide with improved intestinal microbial abundance function and preparation method thereof", "a yak bone peptide with hypoglycemic and antioxidant functions and preparation method thereof", "a yak bone hypotensive peptide with hypoglycemic and antioxidant functions and preparation method thereof", "yak bone hypotensive peptide and preparation method thereof", "yak bone protein peptide with fatigue relief and antioxidant and preparation method", "yak bone protein peptide with DPP-IV inhibitory activity and preparation method" Yak bone protein peptide with ACE inhibition function and preparation method and application" and many other national invention patents, firmly occupy the industry discourse in the field of yak bone peptide.
Those who are good at playing seek momentum, and those who are good at planning will go far, and innovation will always be the first driving force to lead development. The successful acquisition of the invention patent of "nanoparticle peptide" once again demonstrates the innovative breakthrough of the People's Republic of China Peptide Group in focusing on the new generation of bioactive peptide technology. It is believed that in the near future, the "second generation" bioactive peptide products of national peptide with the blessing of a new generation of technology will continue to face the market, provide more "gold" and "new" peptide health products for domestic and global consumers, and tell the story of China's peptide brand to the world!